[Federal Register Volume 85, Number 47 (Tuesday, March 10, 2020)]
[Notices]
[Page 13928]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-04831]



[[Page 13928]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-579]


Bulk Manufacturer of Controlled Substances Application: Sigma 
Aldrich Research

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before May 11, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on December 13, 2019, Sigma Aldrich Research, 
Biochemicals, Inc., 400-600 Summit Drive, Burlington, Massachusetts 
01803 applied to be registered as a bulk manufacturer of the following 
basic class(es) of controlled substances:

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Cathinone..........................            1235  I
Mephedrone (4-Methyl-N-                        1248  I
 methylcathinone).
Lysergic acid diethylamide.........            7315  I
Tetrahydrocannabinols..............            7370  I
3,4-Methylenedioxymethamphetamine..            7405  I
Alpha-methyltryptamine.............            7432  I
Dimethyltryptamine.................            7435  I
5-Methoxy-N,N-diisopropyltryptamine            7439  I
N-Benzylpiperazine.................            7493  I
2-(2,5-Dimethoxyphenyl) ethanamine             7517  I
 (2C-H).
MDPV (3,4-                                     7535  I
 Methylenedioxypyrovalerone).
Methylone (3,4-Methylenedioxy-N-               7540  I
 methylcathinone).
Heroin.............................            9200  I
Normorphine........................            9313  I
Norlevorphanol.....................            9634  I
Amphetamine........................            1100  II
Nabilone...........................            7379  II
Phencyclidine......................            7471  II
Cocaine............................            9041  II
Codeine............................            9050  II
Ecgonine...........................            9180  II
Levorphanol........................            9220  II
Meperidine.........................            9230  II
Methadone..........................            9250  II
Morphine...........................            9300  II
Thebaine...........................            9333  II
Levo-alphacetylmethadol............            9648  II
Noroxymorphone.....................            9668  II
Remifentanil.......................            9739  II
Sufentanil.........................            9740  II
Carfentanil........................            9743  II
Fentanyl...........................            9801  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances to make reference standards for distribution to 
its customers.

    Dated: February 10, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-04831 Filed 3-9-20; 8:45 am]
 BILLING CODE 4410-09-P